Non-COVID research statement
The Oxford Vaccine Group will be continuing with some of our non-COVID research, particularly our paediatric studies, during the COVID-19 pandemic. This is because as part of these studies we give babies their routine primary immunisations on behalf of their GPs. This reduces the administrative burden on the NHS, allowing them to free up capacity and prioritise their workload to be focused on doing what is necessary to manage the response to the COVID-19 pandemic. The participants also benefit from having the vaccines in the safety of their homes or a convenient location.
Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.
Events and Training
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.
There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.
Tadesse BT. et al, (2023), JMIR Public Health Surveill, 9
Hanumunthadu B. et al, (2023), BMJ Open, 13
Pagnamenta AT. et al, (2023), Genome Med, 15
Hill M. et al, (2023), BMJ Open, 13
Abu-Raya B. et al, (2023), J Mol Biol
Monday, 24 June 2024 to Wednesday, 26 June 2024, 10am - 2pm @ St Catherine's College Manor Road Oxford OX1 3UJ
IIC – The ESPID-Oxford Course is a residential training course covering topics in paediatric infection for paediatric infectious diseases trainees and trainers, and for all those who manage children with infections. 2024 will be the 21st edition of the course.